News » Franziska Hartmann
Browse All Categories
Franziska Hartmann

Franziska Hartmann

More from Franziska Hartmann

Franziska Hartmann
By Franziska Hartmann
on August 24, 2022

The age of industry and Pharma 4.0 has long been heralded, but many pharmaceutical companies are still reluctant to switch to fully automated processes. One reason for this is the fear that compliance with regulatory provisions, including those relating to data integrity in pharma, could suffer as a result. However, automation is a solution to counteract the challenges of the pharmaceutical industry’s rapid growth combined with the shortage of skilled workers. This article is intended to dispel the reader's fear of automated processes and to show that investing in automated processes offers financial advantages and simplifies compliance with data integrity regulations.